Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CEBPG
|
ENSG00000153879.4 | CCAAT enhancer binding protein gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CEBPG | hg19_v2_chr19_+_33865218_33865254 | -0.31 | 8.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_186435137 | 28.67 |
ENST00000447445.1
|
KNG1
|
kininogen 1 |
chr3_+_186435065 | 28.22 |
ENST00000287611.2
ENST00000265023.4 |
KNG1
|
kininogen 1 |
chr9_+_117085336 | 17.28 |
ENST00000259396.8
ENST00000538816.1 |
ORM1
|
orosomucoid 1 |
chr9_+_117092149 | 16.20 |
ENST00000431067.2
ENST00000412657.1 |
ORM2
|
orosomucoid 2 |
chr4_+_74269956 | 16.15 |
ENST00000295897.4
ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB
|
albumin |
chr3_+_186330712 | 13.38 |
ENST00000411641.2
ENST00000273784.5 |
AHSG
|
alpha-2-HS-glycoprotein |
chr19_-_4540486 | 12.49 |
ENST00000306390.6
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1 |
chr11_-_18258342 | 11.60 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
chr11_+_18287801 | 11.40 |
ENST00000532858.1
ENST00000405158.2 |
SAA1
|
serum amyloid A1 |
chr11_-_18270182 | 11.26 |
ENST00000528349.1
ENST00000526900.1 ENST00000529528.1 ENST00000414546.2 ENST00000256733.4 |
SAA2
|
serum amyloid A2 |
chr11_+_18287721 | 11.11 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr13_-_46679144 | 10.81 |
ENST00000181383.4
|
CPB2
|
carboxypeptidase B2 (plasma) |
chr16_+_72088376 | 10.70 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
chr13_-_46679185 | 10.24 |
ENST00000439329.3
|
CPB2
|
carboxypeptidase B2 (plasma) |
chr17_-_64225508 | 9.21 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr9_+_130911723 | 8.97 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
chr3_-_120400960 | 8.90 |
ENST00000476082.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chrX_+_138612889 | 8.54 |
ENST00000218099.2
ENST00000394090.2 |
F9
|
coagulation factor IX |
chr3_-_148939835 | 8.28 |
ENST00000264613.6
|
CP
|
ceruloplasmin (ferroxidase) |
chr12_-_96390108 | 8.18 |
ENST00000538703.1
ENST00000261208.3 |
HAL
|
histidine ammonia-lyase |
chr9_+_130911770 | 8.05 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
chr3_-_148939598 | 7.89 |
ENST00000455472.3
|
CP
|
ceruloplasmin (ferroxidase) |
chr2_-_21266935 | 7.76 |
ENST00000233242.1
|
APOB
|
apolipoprotein B |
chr12_-_96390063 | 7.40 |
ENST00000541929.1
|
HAL
|
histidine ammonia-lyase |
chr6_+_31895287 | 7.16 |
ENST00000447952.2
|
C2
|
complement component 2 |
chr7_+_137761199 | 7.03 |
ENST00000411726.2
|
AKR1D1
|
aldo-keto reductase family 1, member D1 |
chr3_-_194072019 | 6.88 |
ENST00000429275.1
ENST00000323830.3 |
CPN2
|
carboxypeptidase N, polypeptide 2 |
chr9_+_80912059 | 6.82 |
ENST00000347159.2
ENST00000376588.3 |
PSAT1
|
phosphoserine aminotransferase 1 |
chr14_-_70263979 | 6.76 |
ENST00000216540.4
|
SLC10A1
|
solute carrier family 10 (sodium/bile acid cotransporter), member 1 |
chr6_-_135271260 | 6.56 |
ENST00000265605.2
|
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
chr6_+_31895467 | 6.53 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr6_-_135271219 | 6.48 |
ENST00000367847.2
ENST00000367845.2 |
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
chr6_+_31895254 | 6.40 |
ENST00000299367.5
ENST00000442278.2 |
C2
|
complement component 2 |
chr1_-_204183071 | 6.29 |
ENST00000308302.3
|
GOLT1A
|
golgi transport 1A |
chr6_+_31895480 | 6.27 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr1_+_196743912 | 6.12 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
chr12_-_323689 | 5.79 |
ENST00000428720.1
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr3_-_49726104 | 5.55 |
ENST00000383728.3
ENST00000545762.1 |
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr8_-_121824374 | 5.50 |
ENST00000517992.1
|
SNTB1
|
syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) |
chr1_+_196743943 | 5.42 |
ENST00000471440.2
ENST00000391985.3 |
CFHR3
|
complement factor H-related 3 |
chr3_-_49726486 | 5.06 |
ENST00000449682.2
|
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr3_-_190580404 | 5.04 |
ENST00000442080.1
|
GMNC
|
geminin coiled-coil domain containing |
chr19_-_6670128 | 4.87 |
ENST00000245912.3
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14 |
chr21_-_37852359 | 4.87 |
ENST00000399137.1
ENST00000399135.1 |
CLDN14
|
claudin 14 |
chr22_-_30901637 | 4.84 |
ENST00000381982.3
ENST00000255858.7 ENST00000540456.1 ENST00000392772.2 |
SEC14L4
|
SEC14-like 4 (S. cerevisiae) |
chr21_-_35899113 | 4.61 |
ENST00000492600.1
ENST00000481448.1 ENST00000381132.2 |
RCAN1
|
regulator of calcineurin 1 |
chr10_-_70092635 | 4.52 |
ENST00000309049.4
|
PBLD
|
phenazine biosynthesis-like protein domain containing |
chr6_-_133055815 | 4.36 |
ENST00000509351.1
ENST00000417437.2 ENST00000414302.2 ENST00000423615.2 ENST00000427187.2 ENST00000275223.3 ENST00000519686.2 |
VNN3
|
vanin 3 |
chr8_-_6795823 | 4.26 |
ENST00000297435.2
|
DEFA4
|
defensin, alpha 4, corticostatin |
chr8_-_6837602 | 4.14 |
ENST00000382692.2
|
DEFA1
|
defensin, alpha 1 |
chr19_+_49259325 | 4.09 |
ENST00000222157.3
|
FGF21
|
fibroblast growth factor 21 |
chr6_-_133055896 | 3.84 |
ENST00000367927.5
ENST00000425515.2 ENST00000207771.3 ENST00000392393.3 ENST00000450865.2 ENST00000392394.2 |
VNN3
|
vanin 3 |
chr11_+_76493294 | 3.74 |
ENST00000533752.1
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chr4_-_111119804 | 3.73 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
chrX_+_46937745 | 3.67 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
chr4_-_111120132 | 3.46 |
ENST00000506625.1
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr20_+_361890 | 3.41 |
ENST00000449710.1
ENST00000422053.2 |
TRIB3
|
tribbles pseudokinase 3 |
chr20_+_361261 | 3.38 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
chr1_-_47655686 | 3.29 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr17_+_812872 | 3.28 |
ENST00000576252.1
|
RP11-676J12.7
|
Uncharacterized protein |
chr19_+_49258775 | 3.28 |
ENST00000593756.1
|
FGF21
|
fibroblast growth factor 21 |
chr11_+_59824060 | 3.26 |
ENST00000395032.2
ENST00000358152.2 |
MS4A3
|
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
chr10_-_14596140 | 3.24 |
ENST00000496330.1
|
FAM107B
|
family with sequence similarity 107, member B |
chr19_+_2476116 | 3.17 |
ENST00000215631.4
ENST00000587345.1 |
GADD45B
|
growth arrest and DNA-damage-inducible, beta |
chr11_+_59824127 | 3.09 |
ENST00000278865.3
|
MS4A3
|
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) |
chr18_+_33767473 | 2.91 |
ENST00000261326.5
|
MOCOS
|
molybdenum cofactor sulfurase |
chr4_-_111120334 | 2.90 |
ENST00000503885.1
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
chr4_+_184020398 | 2.88 |
ENST00000403733.3
ENST00000378925.3 |
WWC2
|
WW and C2 domain containing 2 |
chr17_+_47287749 | 2.78 |
ENST00000419580.2
|
ABI3
|
ABI family, member 3 |
chr19_+_55417530 | 2.73 |
ENST00000350790.5
ENST00000338835.5 ENST00000357397.5 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
chr18_+_72167096 | 2.69 |
ENST00000324301.8
|
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family) |
chr9_+_136399929 | 2.61 |
ENST00000393060.1
|
ADAMTSL2
|
ADAMTS-like 2 |
chr12_+_57522692 | 2.54 |
ENST00000554174.1
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr2_-_216300784 | 2.48 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr11_-_72504681 | 2.47 |
ENST00000538536.1
ENST00000543304.1 ENST00000540587.1 ENST00000334805.6 |
STARD10
|
StAR-related lipid transfer (START) domain containing 10 |
chr14_+_21387491 | 2.43 |
ENST00000258817.2
|
RP11-84C10.2
|
RP11-84C10.2 |
chr9_+_115913222 | 2.42 |
ENST00000259392.3
|
SLC31A2
|
solute carrier family 31 (copper transporter), member 2 |
chr2_+_218994002 | 2.40 |
ENST00000428565.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
chr19_+_6887571 | 2.38 |
ENST00000250572.8
ENST00000381407.5 ENST00000312053.4 ENST00000450315.3 ENST00000381404.4 |
EMR1
|
egf-like module containing, mucin-like, hormone receptor-like 1 |
chr8_+_97597148 | 2.29 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr3_+_46395219 | 2.25 |
ENST00000445132.2
ENST00000292301.4 |
CCR2
|
chemokine (C-C motif) receptor 2 |
chr12_-_8693469 | 2.22 |
ENST00000545274.1
ENST00000446457.2 |
CLEC4E
|
C-type lectin domain family 4, member E |
chr12_+_57522439 | 2.18 |
ENST00000338962.4
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr1_-_1711508 | 2.18 |
ENST00000378625.1
|
NADK
|
NAD kinase |
chr5_+_49962772 | 2.16 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr12_+_57522258 | 2.14 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr19_-_6720686 | 1.97 |
ENST00000245907.6
|
C3
|
complement component 3 |
chr11_-_72504637 | 1.94 |
ENST00000536377.1
ENST00000359373.5 |
STARD10
ARAP1
|
StAR-related lipid transfer (START) domain containing 10 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chrX_-_73512177 | 1.94 |
ENST00000603672.1
ENST00000418855.1 |
FTX
|
FTX transcript, XIST regulator (non-protein coding) |
chr4_-_10023095 | 1.84 |
ENST00000264784.3
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr11_-_124806297 | 1.77 |
ENST00000298251.4
|
HEPACAM
|
hepatic and glial cell adhesion molecule |
chr14_+_21387508 | 1.76 |
ENST00000555624.1
|
RP11-84C10.2
|
RP11-84C10.2 |
chr7_-_121944491 | 1.75 |
ENST00000331178.4
ENST00000427185.2 ENST00000442488.2 |
FEZF1
|
FEZ family zinc finger 1 |
chr9_+_86237963 | 1.72 |
ENST00000277124.8
|
IDNK
|
idnK, gluconokinase homolog (E. coli) |
chr2_-_152146385 | 1.58 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr12_-_57522813 | 1.58 |
ENST00000556155.1
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
chr7_-_144435985 | 1.55 |
ENST00000549981.1
|
TPK1
|
thiamin pyrophosphokinase 1 |
chr12_+_53846594 | 1.55 |
ENST00000550192.1
|
PCBP2
|
poly(rC) binding protein 2 |
chr3_-_42306248 | 1.53 |
ENST00000334681.5
|
CCK
|
cholecystokinin |
chr12_-_8693539 | 1.49 |
ENST00000299663.3
|
CLEC4E
|
C-type lectin domain family 4, member E |
chr11_+_60048004 | 1.48 |
ENST00000532114.1
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A |
chr11_+_60048129 | 1.44 |
ENST00000355131.3
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A |
chr1_+_172389836 | 1.44 |
ENST00000460397.2
|
C1orf105
|
chromosome 1 open reading frame 105 |
chr7_-_8276508 | 1.43 |
ENST00000401396.1
ENST00000317367.5 |
ICA1
|
islet cell autoantigen 1, 69kDa |
chr11_+_60048053 | 1.36 |
ENST00000337908.4
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A |
chr4_+_185909970 | 1.35 |
ENST00000505053.1
|
RP11-386B13.4
|
RP11-386B13.4 |
chr6_-_27799305 | 1.34 |
ENST00000357549.2
|
HIST1H4K
|
histone cluster 1, H4k |
chr2_-_89310012 | 1.34 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr12_+_53846612 | 1.28 |
ENST00000551104.1
|
PCBP2
|
poly(rC) binding protein 2 |
chr19_-_54327542 | 1.25 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
chr1_+_158901329 | 1.19 |
ENST00000368140.1
ENST00000368138.3 ENST00000392254.2 ENST00000392252.3 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr20_+_816695 | 1.13 |
ENST00000246100.3
|
FAM110A
|
family with sequence similarity 110, member A |
chr12_-_10605929 | 1.11 |
ENST00000347831.5
ENST00000359151.3 |
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1 |
chr5_+_36152091 | 1.11 |
ENST00000274254.5
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
chrX_-_73511908 | 1.09 |
ENST00000455395.1
|
FTX
|
FTX transcript, XIST regulator (non-protein coding) |
chr10_+_26986582 | 1.03 |
ENST00000376215.5
ENST00000376203.5 |
PDSS1
|
prenyl (decaprenyl) diphosphate synthase, subunit 1 |
chr17_+_7477040 | 1.01 |
ENST00000581384.1
ENST00000577929.1 |
EIF4A1
|
eukaryotic translation initiation factor 4A1 |
chr5_+_36152179 | 1.00 |
ENST00000508514.1
ENST00000513151.1 ENST00000546211.1 |
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
chr5_+_36152163 | 1.00 |
ENST00000274255.6
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
chr7_-_14026123 | 0.99 |
ENST00000420159.2
ENST00000399357.3 ENST00000403527.1 |
ETV1
|
ets variant 1 |
chr22_-_30867973 | 0.99 |
ENST00000402286.1
ENST00000401751.1 ENST00000539629.1 ENST00000403066.1 ENST00000215812.4 |
SEC14L3
|
SEC14-like 3 (S. cerevisiae) |
chr17_-_39769005 | 0.87 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr14_+_45366518 | 0.85 |
ENST00000557112.1
|
C14orf28
|
chromosome 14 open reading frame 28 |
chr14_+_39703112 | 0.83 |
ENST00000555143.1
ENST00000280082.3 |
MIA2
|
melanoma inhibitory activity 2 |
chr9_+_130860583 | 0.82 |
ENST00000373064.5
|
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr17_+_4699439 | 0.81 |
ENST00000270586.3
|
PSMB6
|
proteasome (prosome, macropain) subunit, beta type, 6 |
chr3_+_46395579 | 0.79 |
ENST00000421659.1
|
CCR2
|
chemokine (C-C motif) receptor 2 |
chr12_+_53835383 | 0.77 |
ENST00000429243.2
|
PRR13
|
proline rich 13 |
chr11_-_102668879 | 0.76 |
ENST00000315274.6
|
MMP1
|
matrix metallopeptidase 1 (interstitial collagenase) |
chr3_+_130569429 | 0.75 |
ENST00000505330.1
ENST00000504381.1 ENST00000507488.2 ENST00000393221.4 |
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1 |
chr17_-_29645836 | 0.74 |
ENST00000578584.1
|
CTD-2370N5.3
|
CTD-2370N5.3 |
chr21_+_34775181 | 0.72 |
ENST00000290219.6
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr6_-_30710510 | 0.71 |
ENST00000376389.3
|
FLOT1
|
flotillin 1 |
chr12_+_53835425 | 0.69 |
ENST00000549924.1
|
PRR13
|
proline rich 13 |
chr9_+_130860810 | 0.65 |
ENST00000433501.1
|
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr1_+_165864800 | 0.65 |
ENST00000469256.2
|
UCK2
|
uridine-cytidine kinase 2 |
chr2_+_65663812 | 0.64 |
ENST00000606978.1
ENST00000377977.3 ENST00000536804.1 |
AC074391.1
|
AC074391.1 |
chr6_-_30710265 | 0.63 |
ENST00000438162.1
ENST00000454845.1 |
FLOT1
|
flotillin 1 |
chr6_+_167704798 | 0.61 |
ENST00000230256.3
|
UNC93A
|
unc-93 homolog A (C. elegans) |
chr12_+_53835508 | 0.60 |
ENST00000551003.1
ENST00000549068.1 ENST00000549740.1 ENST00000546581.1 ENST00000549581.1 ENST00000541275.1 |
PRR13
PCBP2
|
proline rich 13 poly(rC) binding protein 2 |
chr12_-_95510743 | 0.59 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chr2_+_226265364 | 0.59 |
ENST00000272907.6
|
NYAP2
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 |
chr7_-_14026063 | 0.59 |
ENST00000443608.1
ENST00000438956.1 |
ETV1
|
ets variant 1 |
chr5_+_49963239 | 0.58 |
ENST00000505554.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr19_-_40971667 | 0.57 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr6_-_30710447 | 0.55 |
ENST00000456573.2
|
FLOT1
|
flotillin 1 |
chr2_-_191885686 | 0.54 |
ENST00000432058.1
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa |
chr16_+_57220193 | 0.54 |
ENST00000564435.1
ENST00000562959.1 ENST00000394420.4 ENST00000568505.2 ENST00000537866.1 |
RSPRY1
|
ring finger and SPRY domain containing 1 |
chr1_+_93645314 | 0.53 |
ENST00000343253.7
|
CCDC18
|
coiled-coil domain containing 18 |
chr14_+_45366472 | 0.53 |
ENST00000325192.3
|
C14orf28
|
chromosome 14 open reading frame 28 |
chr1_+_165864821 | 0.53 |
ENST00000470820.1
|
UCK2
|
uridine-cytidine kinase 2 |
chr17_-_76124711 | 0.49 |
ENST00000306591.7
ENST00000590602.1 |
TMC6
|
transmembrane channel-like 6 |
chr4_+_86699834 | 0.48 |
ENST00000395183.2
|
ARHGAP24
|
Rho GTPase activating protein 24 |
chr14_-_23292596 | 0.48 |
ENST00000554741.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr14_+_39703084 | 0.48 |
ENST00000553728.1
|
RP11-407N17.3
|
cTAGE family member 5 isoform 4 |
chr2_-_89545079 | 0.45 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
chr5_+_125758865 | 0.44 |
ENST00000542322.1
ENST00000544396.1 |
GRAMD3
|
GRAM domain containing 3 |
chr20_+_54987305 | 0.42 |
ENST00000371336.3
ENST00000434344.1 |
CASS4
|
Cas scaffolding protein family member 4 |
chr3_+_68055366 | 0.40 |
ENST00000496687.1
|
FAM19A1
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 |
chr6_+_167704838 | 0.37 |
ENST00000366829.2
|
UNC93A
|
unc-93 homolog A (C. elegans) |
chr5_-_36152031 | 0.36 |
ENST00000296603.4
|
LMBRD2
|
LMBR1 domain containing 2 |
chr5_+_125758813 | 0.32 |
ENST00000285689.3
ENST00000515200.1 |
GRAMD3
|
GRAM domain containing 3 |
chr1_+_90308981 | 0.32 |
ENST00000527156.1
|
LRRC8D
|
leucine rich repeat containing 8 family, member D |
chr13_-_72441315 | 0.27 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
chr16_+_57220049 | 0.27 |
ENST00000562439.1
|
RSPRY1
|
ring finger and SPRY domain containing 1 |
chr11_-_1776176 | 0.25 |
ENST00000429746.1
|
CTSD
|
cathepsin D |
chr4_+_71226468 | 0.24 |
ENST00000226460.4
|
SMR3A
|
submaxillary gland androgen regulated protein 3A |
chr5_-_135701164 | 0.22 |
ENST00000355180.3
ENST00000426057.2 ENST00000513104.1 |
TRPC7
|
transient receptor potential cation channel, subfamily C, member 7 |
chr20_-_48782639 | 0.22 |
ENST00000435301.2
|
RP11-112L6.3
|
RP11-112L6.3 |
chr19_-_39805976 | 0.21 |
ENST00000248668.4
|
LRFN1
|
leucine rich repeat and fibronectin type III domain containing 1 |
chr19_+_55417499 | 0.21 |
ENST00000291890.4
ENST00000447255.1 ENST00000598576.1 ENST00000594765.1 |
NCR1
|
natural cytotoxicity triggering receptor 1 |
chr6_+_30749649 | 0.20 |
ENST00000422944.1
|
HCG20
|
HLA complex group 20 (non-protein coding) |
chr14_+_96000930 | 0.19 |
ENST00000331334.4
|
GLRX5
|
glutaredoxin 5 |
chr9_-_86323118 | 0.13 |
ENST00000376395.4
|
UBQLN1
|
ubiquilin 1 |
chr1_-_179112173 | 0.10 |
ENST00000408940.3
ENST00000504405.1 |
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr4_-_15661474 | 0.10 |
ENST00000509314.1
ENST00000503196.1 |
FBXL5
|
F-box and leucine-rich repeat protein 5 |
chr19_+_49496705 | 0.09 |
ENST00000595090.1
|
RUVBL2
|
RuvB-like AAA ATPase 2 |
chr22_-_50523807 | 0.06 |
ENST00000442311.1
ENST00000538737.1 |
MLC1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chrX_-_73834449 | 0.06 |
ENST00000332687.6
ENST00000349225.2 |
RLIM
|
ring finger protein, LIM domain interacting |
chr12_-_57039739 | 0.04 |
ENST00000552959.1
ENST00000551020.1 ENST00000553007.2 ENST00000552919.1 ENST00000552104.1 ENST00000262030.3 |
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
chr15_+_67813406 | 0.01 |
ENST00000342683.4
|
C15orf61
|
chromosome 15 open reading frame 61 |
chr14_+_105046094 | 0.01 |
ENST00000331952.2
|
C14orf180
|
chromosome 14 open reading frame 180 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 16.2 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
5.3 | 21.0 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.6 | 10.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
3.4 | 17.0 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.8 | 33.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.6 | 74.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.2 | 15.6 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
1.5 | 3.0 | GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
1.5 | 7.4 | GO:1904640 | response to methionine(GO:1904640) |
1.4 | 7.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
1.4 | 6.9 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.2 | 3.7 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
1.2 | 6.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.2 | 21.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.2 | 13.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.1 | 6.8 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
1.1 | 4.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
1.0 | 4.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.0 | 8.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
1.0 | 7.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.9 | 3.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 10.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.8 | 2.5 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.7 | 52.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 10.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 3.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.5 | 18.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.5 | 4.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.5 | 8.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.4 | 1.7 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.4 | 2.4 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.3 | 2.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 2.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.3 | 1.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 1.6 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 1.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.3 | 6.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 1.6 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.3 | 1.2 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.3 | 1.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.3 | 12.5 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.3 | 6.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 2.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.3 | 5.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 1.9 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 2.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 2.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.2 | 6.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 3.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.5 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 4.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 1.5 | GO:0032096 | positive regulation of glutamate secretion(GO:0014049) negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.1 | 3.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 4.6 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 1.5 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 2.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 5.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 2.9 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 7.3 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.1 | 1.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.6 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 1.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.0 | 1.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 3.3 | GO:0002292 | T cell differentiation involved in immune response(GO:0002292) |
0.0 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.7 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 7.8 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.8 | 7.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 54.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 122.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.4 | 4.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 33.0 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 48.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 5.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 10.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 2.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.8 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.0 | 6.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 10.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 6.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 4.9 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 5.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 73.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.6 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
2.3 | 6.9 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.4 | 7.0 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
1.4 | 8.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.3 | 16.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.3 | 9.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.3 | 7.8 | GO:0035473 | lipase binding(GO:0035473) |
1.2 | 7.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.0 | 6.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.9 | 13.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.8 | 10.1 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.8 | 45.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.7 | 5.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 27.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.7 | 16.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 4.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 3.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 71.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.6 | 2.9 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 2.7 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.4 | 2.6 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 3.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.4 | 2.4 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.3 | 6.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 11.8 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 7.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 8.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 2.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 6.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 1.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.2 | 12.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.1 | 1.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 1.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 35.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 21.3 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 2.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 7.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 1.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 4.5 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 2.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 58.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 22.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 12.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 20.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 16.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 13.4 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 16.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 2.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 4.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 2.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 2.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 11.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 10.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 65.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.3 | 22.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.2 | 39.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 22.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 7.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 6.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 16.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 10.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 7.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 11.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 5.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 4.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 15.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 4.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 2.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |